- Sections
- C - Chimiemétallurgie
- C07C - Composés acycliques ou carbocycliques
- C07C 57/03 - Acides monocarboxyliques
Détention brevets de la classe C07C 57/03
Brevets de cette classe: 261
Historique des publications depuis 10 ans
|
28
|
26
|
9
|
19
|
17
|
14
|
10
|
23
|
12
|
9
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| io Therapeutics, Inc. | 125 |
9 |
| Corbion Biotech, Inc. | 129 |
9 |
| BASF SE | 21308 |
8 |
| University of Southern California | 2134 |
6 |
| BASF Pharma (Callanish) Limited | 32 |
6 |
| Board of Supervisors of Louisiana State University and Agricultural and Mechanical College | 823 |
6 |
| Givaudan SA | 1974 |
6 |
| DSM IP Assets B.V. | 5373 |
5 |
| Arkema France | 4242 |
5 |
| Giuliani S.p.A. | 314 |
5 |
| Nippon Suisan Kaisha, Ltd. | 190 |
5 |
| Pronova Biopharma Norge AS | 63 |
5 |
| Biojiva LLC | 57 |
4 |
| The Regents of the University of California | 20778 |
3 |
| Mars, Incorporated | 2893 |
3 |
| Amarin Pharmaceuticals Ireland Limited | 271 |
3 |
| The Brigham and Women's Hospital, Inc. | 2286 |
3 |
| Cellix Bio Private Limited | 52 |
3 |
| Exerkine Corporation | 37 |
3 |
| Thetis Pharmaceuticals LLC | 23 |
3 |
| Autres propriétaires | 161 |